
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6978495
[patent_doc_number] => 20050288213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Combination therapy for the treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 10/520566
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22007
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288213.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520566 | Combination therapy for the treatment of obesity | Jul 13, 2003 | Abandoned |
Array
(
[id] => 6724563
[patent_doc_number] => 20030206875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Compositions for treating biofilm'
[patent_app_type] => new
[patent_app_number] => 10/465485
[patent_app_country] => US
[patent_app_date] => 2003-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6363
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20030206875.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465485 | Compositions for treating biofilm | Jun 18, 2003 | Abandoned |
Array
(
[id] => 7349628
[patent_doc_number] => 20040047919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Methods and compositions involving aldose reductase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/462223
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 33140
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462223 | Methods and compositions involving aldose reductase inhibitors | Jun 12, 2003 | Abandoned |
Array
(
[id] => 6770519
[patent_doc_number] => 20030216459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Small-molecule modulators of hepatocyte growth factor / scatter factor activities'
[patent_app_type] => new
[patent_app_number] => 10/456326
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18735
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456326 | Small-molecule modulators of hepatocyte growth factor / scatter factor activities | Jun 5, 2003 | Issued |
Array
(
[id] => 7257079
[patent_doc_number] => 20040259918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Combination therapeutic compositions and method of use'
[patent_app_type] => new
[patent_app_number] => 10/456932
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12754
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456932 | Combination therapeutic compositions and method of use | Jun 4, 2003 | Abandoned |
Array
(
[id] => 6702174
[patent_doc_number] => 20030225054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents'
[patent_app_type] => new
[patent_app_number] => 10/453036
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12067
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453036 | Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents | Jun 2, 2003 | Abandoned |
Array
(
[id] => 6874144
[patent_doc_number] => 20030194441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Aqueous pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/344189
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17078
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194441.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344189
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344189 | Aqueous pharmaceutical compositions | Jun 1, 2003 | Abandoned |
Array
(
[id] => 7387126
[patent_doc_number] => 20040029878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Compositions and methods for the treatment of urinary incontinence'
[patent_app_type] => new
[patent_app_number] => 10/448443
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5430
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10448443
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/448443 | Compositions and methods for the treatment of urinary incontinence | May 29, 2003 | Abandoned |
Array
(
[id] => 7614830
[patent_doc_number] => 06897698
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-24
[patent_title] => 'Phase shifting and PWM driving circuits and methods'
[patent_app_type] => utility
[patent_app_number] => 10/448496
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 4409
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10448496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/448496 | Phase shifting and PWM driving circuits and methods | May 29, 2003 | Issued |
Array
(
[id] => 7395151
[patent_doc_number] => 20040018169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Method for reducing oxalate'
[patent_app_type] => new
[patent_app_number] => 10/441157
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8921
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441157 | Method for reducing oxalate | May 18, 2003 | Abandoned |
Array
(
[id] => 7386908
[patent_doc_number] => 20040082623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists'
[patent_app_type] => new
[patent_app_number] => 10/312778
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7443
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312778 | Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists | May 14, 2003 | Abandoned |
Array
(
[id] => 6770350
[patent_doc_number] => 20030216290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/421389
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18587
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216290.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421389 | Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors | Apr 22, 2003 | Issued |
Array
(
[id] => 6825650
[patent_doc_number] => 20030236272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states'
[patent_app_type] => new
[patent_app_number] => 10/421465
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23590
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421465
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421465 | Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states | Apr 22, 2003 | Abandoned |
Array
(
[id] => 6725503
[patent_doc_number] => 20030207815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses'
[patent_app_type] => new
[patent_app_number] => 10/417238
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28694
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207815.pdf
[firstpage_image] =>[orig_patent_app_number] => 10417238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/417238 | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses | Apr 16, 2003 | Issued |
Array
(
[id] => 6830460
[patent_doc_number] => 20030181518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Compositions and methods for treating cystic fibrosis'
[patent_app_type] => new
[patent_app_number] => 10/413953
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4351
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10413953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/413953 | Compositions and methods for treating cystic fibrosis | Apr 14, 2003 | Abandoned |
Array
(
[id] => 6664599
[patent_doc_number] => 20030203925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Pharmaceutical compositions based on anticholinergics and endothelin antagonists'
[patent_app_type] => new
[patent_app_number] => 10/413065
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9338
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10413065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/413065 | Pharmaceutical compositions based on anticholinergics and endothelin antagonists | Apr 13, 2003 | Abandoned |
Array
(
[id] => 7679096
[patent_doc_number] => 20030195240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands'
[patent_app_type] => new
[patent_app_number] => 10/275624
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18357
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275624 | Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands | Apr 13, 2003 | Abandoned |
Array
(
[id] => 1059632
[patent_doc_number] => 06852722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Compositions and methods for stimulating gastrointestinal mobility'
[patent_app_type] => utility
[patent_app_number] => 10/411756
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16044
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852722.pdf
[firstpage_image] =>[orig_patent_app_number] => 10411756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/411756 | Compositions and methods for stimulating gastrointestinal mobility | Apr 10, 2003 | Issued |
Array
(
[id] => 1093262
[patent_doc_number] => 06825232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders'
[patent_app_type] => B2
[patent_app_number] => 10/409730
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6096
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2812
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10409730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/409730 | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders | Apr 8, 2003 | Issued |
Array
(
[id] => 719276
[patent_doc_number] => RE039096
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-05-16
[patent_title] => 'Treatment of skin disorders'
[patent_app_type] => reissue
[patent_app_number] => 10/408788
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 5723
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408788 | Treatment of skin disorders | Apr 2, 2003 | Issued |